5 employees
Oxyrane UK is a biopharmaceutical company developing biosuperior enzyme replacement therapies to treat inherited diseases.
2007
$27M
from 2 investors over 2 rounds
Oxyrane raised $27M on November 17, 2011
Investors: - and Forbion